+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Investigation on the inclusion behavior of neutral red with beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin



Investigation on the inclusion behavior of neutral red with beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin



Analytica Chimica Acta 474(1-2): 189-195, 9 December



The formation of the inclusion complexes of neutral red (NR) with cyclodextrins (CDs) including beta-cyclodextrin (beta-CD), hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and sulfobutylether-beta-cyclodextrin (SBE-beta-CD) was studied by fluorescence and UV-Vis absorption spectroscopy and the binding constants (K) of the inclusion complexes were obtained by steady-state fluorescence measurements. Experimental conditions including the concentrations of various CDs and media acidity were investigated in detail. The results suggested that NR exists in two molecular forms in aqueous solution (the acidic form and the neutral form). CDs were most suitable for inclusion of the neutral form of NR and could cause enhanced fluorescence emission and absorption by NR. Moreover, the effect of the charged CD (SBE-beta-CD) was quite different from that of the uncharged CDs (beta-CD and HP-beta-CD). A mechanism is proposed to explain the inclusion process.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010880962

Download citation: RISBibTeXText


Related references

Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions. European Journal of Pharmaceutical Sciences 34(2-3): 94-103, 2008

Improved dissolution and bioavailability of phenytoin by sulfobutylether-beta-cyclodextrin ((SBE)7m-beta-CD) and hydroxypropyl-beta-cyclodextrin (HP-beta-CD) complexation. International Journal of Pharmaceutics (Amsterdam) 165(1): 69-78, 1998

Solubilization of the neutral and charged forms of 2,4,6-trichlorophenol by beta-cyclodextrin, methyl-beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in water. Journal of Hazardous Materials 100(1-3): 109-116, 2003

Analytical study of photodegradation of inclusion complexes of nimodipine with alpha-, gamma-cyclodextrin, methyl-beta-cyclodextrin, and hydroxypropyl-beta-Cyclodextrin. Drug Development and Industrial Pharmacy 24(2): 197-200, 2004

Improved dissolution and bioavailability of phenytoin by sulfobutylether-beta-cyclodextrin 7m-beta-CD and hydroxypropyl-beta-cyclodextrin. International Journal of Pharmaceutics (Amsterdam) 165(1): 69-78, April 20, 1998

Fluorescence study on the inclusion complexes of rutin with beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and gamma-cyclodextrin. Analytical Letters 30(12): 2261-2270, 1997

Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method. Official Gazette of the United States Patent & Trademark Office Patents 1245(3), Apr 17, 2001

Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments. European Journal of Pharmaceutical Sciences 18(5): 285-296, 2003

The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes. International Journal of Pharmaceutics 270(1-2): 149-166, 2004

Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state. Journal of Pharmacy and Pharmacology 45(12): 1028-1032, 1993

Preparation and evaluation of dermatological formulations based on inclusion of tretinoin in beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Journal of Investigative Dermatology 100(2): 219, 1993

Solubilization of the neutral and charged forms of 2,4,6-trichlorophenol by hydroxypropyl-beta-cyclodextrin, or methyl-beta-cyclodextrin in water. Journal of Hazardous Materials 108(1-2): 129-131, 2004

Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Journal of Pharmaceutical and Biomedical Analysis 40(1): 122-127, 2005

Photochemical stability of the inclusion complexes of nicardipine with alpha-, gamma-cyclodextrin, methyl-beta-cylodextrin and hydroxypropyl-beta-cyclodextrin in the solid state and in solution. Pharmazie 51(7): 477-479, 1996

Study on the inclusion complexes of cryptotanshinone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 59(12): 2759-2766, 2003